Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory Aggressive B-cell Lymphomas

Explore clinical trials studying Relapsed/Refractory Aggressive B-cell Lymphomas. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Relapsed/Refractory Aggressive B-cell Lymphomas trial results

Completed

Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas

NCT02271945

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site The Bronx, New York, United States
View Trial Details

Related conditions